Level Bio AB (FRA:4MB) FCF Margin %: -13.41% (As of Mar. 2026)


FRA:4MB Level Bio AB FRA:4MB
23 GF Score
Price €0.01
! 4 Warning Signs
View Full Analysis

What is Level Bio AB FCF Margin %?

Level Bio AB FRA:4MB +8.00% 23 FCF Margin % is -13.41% as of Mar. 2026. GuruFocus rates FRA:4MB with a GF Score™ of 23/100. The stock has 4 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Level Bio AB ranks better than 50.49% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Level Bio AB's Free Cash Flow for the three months ended in Mar. 2026 was €-0.11 Mil. Level Bio AB's Revenue for the three months ended in Mar. 2026 was €0.84 Mil. Therefore, Level Bio AB's FCF Margin % for the quarter that ended in Mar. 2026 was -13.41%.

As of today, Level Bio AB's current FCF Yield % is -3.02%.

The historical rank and industry rank for Level Bio AB's FCF Margin % or its related term are showing as below:

FRA:4MB' s FCF Margin % Range Over the Past 10 Years
Min: -21.03   Med: 1.47   Max: 7.82
Current: -1.63

During the past 13 years, the highest FCF Margin % of Level Bio AB was 7.82%. The lowest was -21.03%. And the median was 1.47%.

FRA:4MB's FCF Margin % is ranked better than
50.49% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: -1.845 vs FRA:4MB: -1.63

Level Bio AB FCF Margin % Related Terms

Level Bio AB FCF Margin % Historical Data

* Premium members only.

The historical data trend for Level Bio AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Level Bio AB FCF Margin % Chart

Level Bio AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.69 7.52 -21.05 -17.78 2.52

Level Bio AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.82 0.53 -8.31 12.59 -13.41

FRA:4MB vs TMO, DHR, IDXX: FCF Margin % Comparison

For the Diagnostics & Research subindustry, Level Bio AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Level Bio AB FCF Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Level Bio AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Level Bio AB's FCF Margin % falls into.


FRA:4MB
23GF Score
Level Bio AB FRA:4MB
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Level Bio AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Level Bio AB's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=0.075/2.974
=2.52 %

Level Bio AB's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.112/0.835
=-13.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -13.41% mean?
Level Bio AB (FRA:4MB) has a FCF Margin % of -13.41% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Level Bio AB and its competitors. According to the industry distribution chart, Level Bio AB ranks #101 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 49.5%.
Is Level Bio AB's FCF Margin % too high?
Level Bio AB's current FCF Margin % is -13.41%. Based on the distribution chart, Level Bio AB ranks #101 out of 204 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Level Bio AB has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Level Bio AB's FCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Level Bio AB ranks #101 out of 204 companies for FCF Margin %. This puts Level Bio AB in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Level Bio AB and its competitors. Level Bio AB's current FCF Margin % is -13.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Level Bio AB stock overvalued right now?
Level Bio AB (FRA:4MB) has a current FCF Margin % of -13.41%. The current FCF Margin % is -13.41%. Level Bio AB's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Level Bio AB (FRA:4MB), the current FCF Margin % is -13.41% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Level Bio AB Business Description

Other Exchanges LEVBIO:Sweden
Address Vastra Finnbodavagen 4B, Nacka, Stockholm, SWE, 131 30
Level Bio AB is a parent company and operates through subsidiary. It develops and manufactures diagnostic kits for the clinical market and also is a distributor and full service partner to molecular biology labs in the Nordics.
23GF Score

Get the complete analysis for FRA:4MB

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.01
Price